| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eb9c6b40161bafe7bd55f0b4defcea04 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2017-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3927d006f413ac30a8a8678a305d6482
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a6df0d5e465d3eebc1fa3c6fa8e332b4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_df13d0f277ddbd7f6d2881e6e0f7f28a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bcc89e544a6a39472025f819178f207e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9d215db0e86eec95bae03ea28458ec8e |
| publicationDate |
2017-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2017189999-A1 |
| titleOfInvention |
Hck as a therapeutic target in myd88 mutated diseases |
| abstract |
Methods of treatment of conditions or diseases associated with myeloid differentiation primary response (MYD88) protein using a selective HCK inhibitor are provided herein. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021071919-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11739385-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021247845-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3986397-A4 |
| priorityDate |
2016-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |